Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Cash from Operations: 2018-2024

Historic Cash from Operations for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $108.8 million.

  • CureVac N.V's Cash from Operations rose 50.39% to -$47.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $226.6 million, marking a year-over-year increase of 172.23%. This contributed to the annual value of $108.8 million for FY2024, which is 137.76% up from last year.
  • CureVac N.V's Cash from Operations amounted to $108.8 million in FY2024, which was up 137.76% from -$288.2 million recorded in FY2023.
  • In the past 5 years, CureVac N.V's Cash from Operations registered a high of $622.9 million during FY2020, and its lowest value of -$838.7 million during FY2021.
  • In the last 3 years, CureVac N.V's Cash from Operations had a median value of -$288.2 million in 2023 and averaged -$157.1 million.
  • In the last 5 years, CureVac N.V's Cash from Operations surged by 747.07% in 2020 and then plummeted by 234.65% in 2021.
  • CureVac N.V's Cash from Operations (Yearly) stood at $622.9 million in 2020, then slumped by 234.65% to -$838.7 million in 2021, then soared by 65.19% to -$292.0 million in 2022, then increased by 1.28% to -$288.2 million in 2023, then surged by 137.76% to $108.8 million in 2024.